Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    11387350 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Molecular Imaging of Fulvestrant Effects on Availability of ER Binding Sites
Condition: Metastatic Breast Cancer
Intervention: Other: Diagnostic intervention: Positron Emission Tomography with 16-alpha-[18-fluoro]-17betaestradiol

Indicates status has not been verified in more than two years